---
schema_version: "secwatch.filing_event.v1"
accession: "0001650664-23-000026"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2023-11-22T23:59:59+00:00"
generated_at: "2026-06-07T22:16:14.895189+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine amends severance plan, extending CEO benefits to 18 months post-change-of-control

## Summary
- Amended plan extends change-in-control termination window to include 3 months prior to a change in control.
- Non-change-in-control termination now includes term for Good Reason; requires termination >3 months prior to change.
- CEO severance: base salary continuation extended to 18 months (was 12) and COBRA contributions also to 18 months.
- Plan covers named executive officers and other designated employees under an unfunded welfare benefit plan.

## SEC filing metadata
- accession: 0001650664-23-000026
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2023-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000165066423000026/0001650664-23-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000165066423000026/edit-20231116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001650664-23-000026
- JSON: https://secwatch.observer/filing/0001650664-23-000026.json
- Plain text: https://secwatch.observer/filing/0001650664-23-000026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.